ArticleOncoTargets and therapy2016

Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study.

Kun-Yuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.